# 바이오스페이스 일일 뉴스 리포트 - 2025년 04월 18일


## 주요 헤드라인

1. **Biotech’s Next Phase Will Be All-American (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biotechs-next-phase-will-be-all-american-pitchbook>

2. **Biotech’s Next Phase Will Be All-American (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biotechs-next-phase-will-be-all-american-pitchbook>

3. **Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sanofi-bets-more-than-1-8-billion-in-biobucks-on-ai-developed-bispecifics>

4. **Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sanofi-bets-more-than-1-8-billion-in-biobucks-on-ai-developed-bispecifics>

5. **Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/kennedys-hunt-for-a-connection-between-vaccines-and-autism-is-a-sham>

6. **Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/kennedys-hunt-for-a-connection-between-vaccines-and-autism-is-a-sham>

7. **Lilly Skyrockets on ‘Injectable-Like Efficacy’ for Oral GLP-1 in Phase III Diabetes Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-skyrockets-on-injectable-like-efficacy-for-oral-glp-1-in-phase-iii-diabetes-trial>


---
*2025년 04월 18일 바이오스페이스 뉴스 피드에서 생성된 리포트*